New Results
FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice
Steven Findlay, John Heath, Vincent M. Luo, View ORCID ProfileAbba Malina, Théo Morin, Billel Djerir, Zhigang Li, Arash Samiei, Estelle Simo-Cheyou, Martin Karam, Halil Bagci, Dolev Rahat, Damien Grapton, Elise G. Lavoie, Christian Dove, Husam Khaled, Hellen Kuasne, Koren K. Mann, Kathleen Oros Klein, Celia M. Greenwood, Yuval Tabach, Morag Park, View ORCID ProfileJean-Francois Côté, Alexandre Maréchal, Alexandre Orthwein
doi: https://doi.org/10.1101/365460
Steven Findlay
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
2Division of Experimental Medicine, McGill University, Montreal, Quebec, H4A 3J1, Canada;
John Heath
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
2Division of Experimental Medicine, McGill University, Montreal, Quebec, H4A 3J1, Canada;
Vincent M. Luo
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
3Department of Microbiology and Immunology, McGill University, Montreal, Quebec, H3A 2B4, Canada;
Abba Malina
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
4Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, H4A 3T2, Canada;
Théo Morin
5Department of Biology, Université de Sherbrooke, Sherbrooke, Quebec, J1K 2R1, Canada;
Billel Djerir
5Department of Biology, Université de Sherbrooke, Sherbrooke, Quebec, J1K 2R1, Canada;
Zhigang Li
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
Arash Samiei
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
2Division of Experimental Medicine, McGill University, Montreal, Quebec, H4A 3J1, Canada;
Estelle Simo-Cheyou
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
4Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, H4A 3T2, Canada;
Martin Karam
2Division of Experimental Medicine, McGill University, Montreal, Quebec, H4A 3J1, Canada;
Halil Bagci
6Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, H2W 1R7, Canada
10Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, H3A OC7, Canada
Dolev Rahat
7Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, 91120, Jerusalem, Israel
Damien Grapton
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
Elise G. Lavoie
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
Christian Dove
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
2Division of Experimental Medicine, McGill University, Montreal, Quebec, H4A 3J1, Canada;
Husam Khaled
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
2Division of Experimental Medicine, McGill University, Montreal, Quebec, H4A 3J1, Canada;
Hellen Kuasne
9Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, H3A 1A3, Canada
Koren K. Mann
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
2Division of Experimental Medicine, McGill University, Montreal, Quebec, H4A 3J1, Canada;
4Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, H4A 3T2, Canada;
Kathleen Oros Klein
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
Celia M. Greenwood
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
8Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, H3A 1A2, Canada
Yuval Tabach
5Department of Biology, Université de Sherbrooke, Sherbrooke, Quebec, J1K 2R1, Canada;
Morag Park
9Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, H3A 1A3, Canada
Jean-Francois Côté
6Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, H2W 1R7, Canada
10Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, H3A OC7, Canada
11Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
12Département de Médecine (Programmes de Biologie Moléculaire), Université de Montréal, Montreal, Quebec, H3C 3J7, Canada
Alexandre Maréchal
5Department of Biology, Université de Sherbrooke, Sherbrooke, Quebec, J1K 2R1, Canada;
Alexandre Orthwein
1Lady Davis Institute for Medical Research, Segal Cancer Centre, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, Quebec, H3T 1E2, Canada;
2Division of Experimental Medicine, McGill University, Montreal, Quebec, H4A 3J1, Canada;
3Department of Microbiology and Immunology, McGill University, Montreal, Quebec, H3A 2B4, Canada;
4Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, H4A 3T2, Canada;
Posted July 11, 2018.
FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice
Steven Findlay, John Heath, Vincent M. Luo, Abba Malina, Théo Morin, Billel Djerir, Zhigang Li, Arash Samiei, Estelle Simo-Cheyou, Martin Karam, Halil Bagci, Dolev Rahat, Damien Grapton, Elise G. Lavoie, Christian Dove, Husam Khaled, Hellen Kuasne, Koren K. Mann, Kathleen Oros Klein, Celia M. Greenwood, Yuval Tabach, Morag Park, Jean-Francois Côté, Alexandre Maréchal, Alexandre Orthwein
bioRxiv 365460; doi: https://doi.org/10.1101/365460
FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice
Steven Findlay, John Heath, Vincent M. Luo, Abba Malina, Théo Morin, Billel Djerir, Zhigang Li, Arash Samiei, Estelle Simo-Cheyou, Martin Karam, Halil Bagci, Dolev Rahat, Damien Grapton, Elise G. Lavoie, Christian Dove, Husam Khaled, Hellen Kuasne, Koren K. Mann, Kathleen Oros Klein, Celia M. Greenwood, Yuval Tabach, Morag Park, Jean-Francois Côté, Alexandre Maréchal, Alexandre Orthwein
bioRxiv 365460; doi: https://doi.org/10.1101/365460
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)